These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10565994)

  • 1. FTY 720.
    Drugs R D; 1999 Jan; 1(1):78-80. PubMed ID: 10565994
    [No Abstract]   [Full Text] [Related]  

  • 2. Sirolimus. AY 22989, NSC 226080, NSC 606698, rapamycin, Rapamune.
    Drugs R D; 1999 Jan; 1(1):100-7. PubMed ID: 10566001
    [No Abstract]   [Full Text] [Related]  

  • 3. Leflunomide. Arava, HWA 486, SU 101.
    Drugs R D; 1999 Jan; 1(1):87-91. PubMed ID: 10565997
    [No Abstract]   [Full Text] [Related]  

  • 4. FTY720: a new immunosuppressive agent with novel mechanism(s) of action.
    Kahan BD
    Transplant Proc; 1998 Aug; 30(5):2210-3. PubMed ID: 9723444
    [No Abstract]   [Full Text] [Related]  

  • 5. Inolimomab. Anti-CD25 monoclonal antibody B-B10, anti-interleukin-2 receptor monoclonal antibody B-B10, B-B10, BT 563, Leukotac.
    Drugs R D; 1999 Jan; 1(1):81-4. PubMed ID: 10565995
    [No Abstract]   [Full Text] [Related]  

  • 6. FTY720 markedly increases alloengraftment but does not eliminate host anti-donor T cells that cause graft rejection on its withdrawal.
    Taylor PA; Kelly RM; Bade ND; Smith MJ; Stefanski HE; Blazar BR
    Biol Blood Marrow Transplant; 2012 Sep; 18(9):1341-52. PubMed ID: 22728248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BTI 322. Anti-CD2 monoclonal antibody, Lo-CD2-a, monoclonal antibody Lo-CD2-a.
    Drugs R D; 1999 Jan; 1(1):68-70. PubMed ID: 10565990
    [No Abstract]   [Full Text] [Related]  

  • 8. FTY: not just a homely drug.
    Calne SR
    Transplantation; 2004 May; 77(9):1327. PubMed ID: 15167585
    [No Abstract]   [Full Text] [Related]  

  • 9. Tresperimus. LF 080299.
    Drugs R D; 1999 Jan; 1(1):110-1. PubMed ID: 10566003
    [No Abstract]   [Full Text] [Related]  

  • 10. FTY720, a novel transplantation drug, modulates lymphocyte migratory responses to chemokines.
    Chen S; Bacon KB; Garcia G; Liao R; Pan ZK; Sullivan SK; Nakano H; Matsuzawa A; Brinkmann V; Feng L
    Transplant Proc; 2001; 33(7-8):3057-63. PubMed ID: 11750317
    [No Abstract]   [Full Text] [Related]  

  • 11. MEDI 500. Anti-TCR-alpha beta monoclonal antibody T10B9, G 022, T-10B9, T10B9, T10B9 monoclonal antibody, T10B9.1A31, T12A10.
    Drugs R D; 1999 Jan; 1(1):92-4. PubMed ID: 10565998
    [No Abstract]   [Full Text] [Related]  

  • 12. Fingolimod: a novel immunosuppressant for multiple sclerosis.
    Brown BA; Kantesaria PP; McDevitt LM
    Ann Pharmacother; 2007 Oct; 41(10):1660-8. PubMed ID: 17785617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTY720: A new kid on the block for transplant immunosuppression.
    Aki FT; Kahan BD
    Expert Opin Biol Ther; 2003 Jul; 3(4):665-81. PubMed ID: 12831371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical evaluation of a new immunosuppressive agent, FTY720.
    Troncoso P; Kahan BD
    Clin Biochem; 1998 Jul; 31(5):369-73. PubMed ID: 9721436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fingolimod - a new immunomodulator].
    Friedrich FW; Eschenhagen T
    Dtsch Med Wochenschr; 2009 Oct; 134(42):2127-31. PubMed ID: 19809964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Infections and fingolimod].
    Cervera C
    Rev Neurol; 2012 Aug; 55(4):227-37. PubMed ID: 22829086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FTY720 blocks allograft rejection by homing of lymphocytes in vivo.
    Yuzawa K; Stephkowski SM; Wang M; Kahan BD
    Transplant Proc; 2000 Mar; 32(2):269. PubMed ID: 10715413
    [No Abstract]   [Full Text] [Related]  

  • 18. An effect of FTY720 on acute rejection in canine renal transplantation.
    Yuzawa K; Otsuka M; Taniguchi H; Takada Y; Sakurayama N; Jinzenji Y; Suzuki S; Fukao K
    Transplant Proc; 1998 Jun; 30(4):1046. PubMed ID: 9636422
    [No Abstract]   [Full Text] [Related]  

  • 19. Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD).
    Taylor PA; Ehrhardt MJ; Lees CJ; Tolar J; Weigel BJ; Panoskaltsis-Mortari A; Serody JS; Brinkmann V; Blazar BR
    Blood; 2007 Nov; 110(9):3480-8. PubMed ID: 17606761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New drugs may improve, complicate treatment for multiple sclerosis.
    Link H; Martin R
    Nat Med; 2010 Mar; 16(3):272. PubMed ID: 20208513
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.